Skip to content

Randomized double-blind, placebo-controlled clinical trial for Bu-Shen Jiang-Ya Granules in treating patients with essential hypertension of kidney deficiency type

Randomized double-blind, placebo-controlled clinical trial for Bu-Shen Jiang-Ya Granules in treating patients with essential hypertension of kidney deficiency type

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002876
Enrollment
Unknown
Registered
2019-12-27
Start date
2020-01-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hypertension

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. patients diagnosed with mild to moderate essential hypertension diagnosed by western medicine: continuous blood pressure or 3 or more non-same day sitting systolic blood pressures >=140 mmHg and =90 mmHg and <110 mmHg; 3. The diagnosis of TCM accorded with kidney deficiency syndrome; 4. the patients signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension (symptomatic hypertension); 2. severe heart failure; 3. insulin-dependent diabetes mellitus; 4. infectious disease; 5. hyperthyroidism; 6. Patients with primary diseases such as liver, kidney, hematopoietic system, nervous system, and psychiatric diseases, malignant tumors; 7. patients participating in other clinical trials; 8. pregnant or lactating women; 9. recent history of trauma.

Design outcomes

Primary

MeasureTime frame
24-hour ambulatory blood pressure;Office blood pressure;

Secondary

MeasureTime frame
Quality of Life;

Countries

China

Contacts

Public ContactXingjiang Xiong
5administration@163.com+86 15801463736

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026